Transcutaneous Vagus Nerve Stimulation for Fibromyalgia Pain and Autonomic Dysfunction
Official title: RESET-FMS: A Randomized Sham-Controlled Trial of Transcutaneous Vagus Nerve Stimulation for Pain, Autonomic Dysfunction, and Fatigue in Patients With Fibromyalgia Syndrome
Run by University of Roma La Sapienza · NCT07682090 · Data updated 2026-11-12
This study tests a non-invasive nerve stimulation method to see if it helps people with fibromyalgia who have widespread pain and autonomic symptoms.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 70 Years |
| Sex | Women only |
| Enrollment | 80 (estimated) |
| Sponsor | University of Roma La Sapienza Academic / other |
| Locations | 1 site (Rome, Lazio) |
| Status | Recruiting |
| Started | June 8, 2026 |
| Main results expected | May 25, 2027 |
| Study ends | September 30, 2027 |
| Registry record updated | July 2, 2026 |
| Trial ID | NCT07682090 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with fibromyalgia who meet the 2016 ACR/EULAR criteria and have stable medications for at least 1 month.
✕Probably not a fit
Individuals with active implants, significant cardiac disease, severe cardiac arrhythmias, uncontrolled medical conditions, or recent changes in therapy may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study explores whether transcutaneous vagus nerve stimulation (tVNS) can improve pain and autonomic function in adults with fibromyalgia syndrome. Participants will receive active tVNS or sham stimulation in a controlled setting, allowing assessment of changes in symptoms and autonomic responses. The trial focuses on individuals with stable medications and excludes those with certain cardiovascular, systemic, or pregnancy-related risks. Outcomes will include patient-reported pain, fatigue, sleep, and objective autonomic measures. The study is conducted at the Department of Human Neuroscience in Rome under lead sponsorship at Università di Roma La Sapienza with collaboration from Policlinico Umberto I.
Why it matters
Potential benefit: If successful, participants may experience reductions in pain and improvements in autonomic regulation and overall quality of life.
How similar studies have gone: Prior research supports autonomic modulation approaches in fibromyalgia, but the effectiveness of tVNS specifically for this condition is still being established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of fibromyalgia syndrome according to the 2016 ACR/EULAR classification criteria; * Stable pharmacological treatment for at least 1 month before enrollment; * Ability to understand and complete study procedures and questionnaires; * Ability to provide written informed consent. Exclusion Criteria: * Presence of an active implantable medical device or any implanted metallic or electronic device near the ear or heart; * History of severe coronary artery disease or myocardial infarction; * Heart failure classified as New York Heart Association (NYHA) class II-IV; * Cardiac arrhythmias or severe bradycardia; * Carotid artery atherosclerosis; * Chronic kidney disease stage II or higher; * Concomitant immune-mediated rheumatic disease; * Pregnancy; * Active malignancy or previous malignancy not in remission; * Ongoing infection; * Changes in pharmacological treatment within 1 month before enrollment; * Concomitant central or peripheral nervous system disorders, except isolated small-fiber pathology on skin biopsy; * Cognitive impairment detected during neurological examination; * Severe psychiatric comorbidities requiring specific treatment; * Pain caused by other medical conditions that cannot be distinguished from fibromyalgia-related pain; * Current or previous alcohol or substance abuse; * Inadequate understanding of the Italian language.
Where it's running
-
Department of Human Neuroscience
Rome, Lazio, Italy Recruiting
Study contacts
- Principal investigator: Andrea Truini, MD, PhD — University of Roma La Sapienza
- Study coordinator: Pietro Falco, MD, PhD
- Email: pietro.falco@uniroma1.it
- Phone: +393462159105
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Yangyin Roujin Formula for Fibromyalgia: Does it help pain and function?
A randomized, double-blind study tests whether Yangyin Roujin Decoction can ease pain and improve function for adults with fibromyalgia compared with a placebo.
-
Auricular acupuncture to balance autonomic function and pain in fibromyalgia
This study tests whether semi-permanent ear acupuncture can improve autonomic regulation and pain sensitivity in adult women with fibromyalgia over five weeks.
-
Yishen Shujin Decoction for adults with fibromyalgia.
This 24-week randomized, double-blind, placebo-controlled trial will test whether Yishen Shujin Decoction reduces pain and improves symptoms in adults with fibromyalgia.
-
Effect of raising a child with ADHD on mothers' fibromyalgia burden
We will see if mothers aged 18–50 who have fibromyalgia and a child with ADHD have more disease burden than mothers with fibromyalgia whose children do not have psychiatric disorders.
-
Forward head posture and symptom severity in fibromyalgia
See if forward head posture, measured by the craniovertebral angle, is linked to symptom severity in adults aged 18–55 with fibromyalgia.
-
Shiatsu therapy for long-lasting non-inflammatory pain in children and teens
This study will try weekly 30-minute Shiatsu sessions alongside regular care to see if they improve quality of life for children and adolescents (ages 10–18) with non-inflammatory chronic pain.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.